Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial - Schell, Marianne; Pflüger, Irada; Brugnara, Gianluca; Isensee, Fabian; Neuberger, Ulf; Foltyn-Dumitru, Martha; Keßler, Tobias; Sahm, Felix; Wick, Antje; Nowosielski, Martha; Heiland, Sabine; Weller, Michael; et al. (Neuro-Oncology, 2020)
Gesehen am 16.02.2021